Clinical Research focus

2012 advertising rates & schedule published

This issue

• Consent, Information & Language: ICR Symposium Debate
  Dr Jane Barrett, Dr Hugh Davies, Prof. Vikki Entwhistle and Kelly Gleason discuss attitudes towards research and how these can be reflected in the language, length and level of detail used in the informed consent process.
• The Future of the EU Clinical Trials Directive We report a speech given by EU Commissioner John Dalli, in which he sets out the next steps for the revision of the Clinical Trials Directive. Of particular importance, he confirms the intention to make these revisions by way of a Regulation, that does not require separate transposition into national law in each Member State.
  
• Cheaper, Faster… Safer? Pharmacovigilance, ADRs & Transferability of Global Study Data Paul Wathall and colleagues explore some of the current developments in pharmacovigilance and how they might impact on the transferability of global study data to local prescribing environments.
• Understanding Risk-Based Monitoring: An interview Jane Tucker discusses how to decide what level of monitoring to do at which site, what industry has to gain from risk-based monitoring and what is changing to enable it to become part of the mainstream of clinical development.
• Effective Project Management Systems: An interview In an online-only interview, Keith Rodgers shares his wisdom from many years working in project management in clinical research and other business units within the pharamceutical industry.
• Your Future in Your Hands Sandy Prasad explains why taking personal control of your own development is essential, and offers some tips to start you on your journey.
• The Other Performance Gap Andrew Smith explores the "Other Performance Gap", as highlighted in a new report by the CSDD at Tufts University… and this time it points squarely at industry…
• Introduction & Personal Vision: Message from the Board Danielle Jacobs is one of the recent group of new members of the ICR Board of Directors. In this month's Message from the Board, she introduces herself and her priorities for the development of our profession.
  

Last issue

• Developing the Next Generation of Professional Training. Training is something that ICR has always done very well. Janette and Paul discuss our new initiative to harmonise training across the industry, along with our other exciting developments in client-hosted training, elearning and "virtual academies".
  
• Triumph of the Market over Science? Andrew Smith's comment on the continuing importance of stem cell research after Geron announces its decision to abandon the field
• Streamling Multicentre Trial Applications in the Netherlands. Edgar Smeets reports on a proposal to reform the processes around ethics review of multicentre studies conducted in the Netherlands.
• NIHR CRN Embedded in UK Industry Practice. The number of commercial studies adopted to the National Institute for Health Research Clinical Research Network Portfolio (NIHR CRN) in the UK has continued to increase over the last five years. Daniel Spiers of the NIHR CRN reports...
• Finding Work as a Freelancer: ICR Freelance Forum. Danielle Jacobs and Rukhsana Shaikh-Zaidi report from this month's ICR Freelance Forum, which included detailed discussions on trends in freelance working and the increasing role of agencies.
• Inspirational Leadership: An interview with Steve Read. A world-renowned leadership coach speaks with us about leadership in business and how professionals in the pharmaceutical industry can develop their leadership skills.
• Striking a Balance: Innovation, Rational economics & Value-based pricing. This report from the ICR 2011 Annual Conference, looks at some of financial factors driving the NHS and wider healthcare industry and how these factors might shape the future of research in the UK.
• International GCP Inspections: The EMA Perspective. In this report from the ICR 2011 Annual Conference, Ana Rodriguez of the European Medicines Agency discusses the pilot programme of joint GCP inspections conducted with the FDA.

About CRfocus

Clinical Research focus (CRfocus) is ICR's peer-reviewed journal, published every month. CRfocus publishes authoritative articles to keep readers up to date with best practice, and develop their careers. Members of ICR receive CRfocus free of charge; non-members can subscribe for £135 per year